Articles

With the discovery of a compound that can slow the degradation of insulin in mice, scientists have opened the door to a potential new treatment for diabetes…. 

In order for a patient to obtain maximum benefit from an insulin pump, uniform training programs must be developed…. 

Call for guidelines for prediabetes from the Clinical Endocrinologists meeting….

Compared with routine care, early intensive multifactorial therapy shows little effect…. 

The SGLT2 inhibitor canagliflozin could help type 2 diabetes patients who fail to control their disease with diet and exercise…. 

Among patients who don’t have diabetes, high-normal HbA1c levels (at or above 5.8%) are strongly correlated with the risk of coronary artery disease…. 

Intensive insulin treatment extended life by more than two years after acute myocardial infarction (AMI) in patients with diabetes compared with standard treatment….

Testosterone supplementation has an insulin sensitizing effect in patients with diabetes…. 

Severe insulin resistance, seen only through more extreme measurements, was identified in adolescent girls with and obesity…. 

This year at AACE, two studies were presented demonstrating liraglutide’s potential benefits in new patient populations. According to the studies, liraglutide appears to work both as an add-on to insulin in type 1 diabetes and as a weight-loss agent in nondiabetic patients.